Structural MRI is routinely acquired in clinical practice, yet quantitative morphometry has had limited impact on clinical decision-making. Overlapping symptoms, trajectories and comorbidities remain difficult to interpret within disease-specific frameworks, leaving it unclear how individual patients relate to the broa...
C. Dalby, A. Dibble, S. Benini et al.· medRxiv· 1 citation
In a contemporary, diverse cohort, most established dementia risk algorithms had limited power in discriminating amyloid positivity, pTau-217 positivity, and current cognitive status despite acceptable calibration.
K. Mavromati, A. Dibble, L. Tvrdá et al.· medRxiv· 0 citations
A multivariate blood-based framework integrating 19 molecular assays and six risk instruments in the Bio-Hermes-001 cohort supports resilience and resistance as molecularly distinct subgroups and provides a scalable framework for pathology-informed stratification and mechanistic investigation.
K. Mavromati, C. Dalby, A. Dibble et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.